MDxHealth SA (MDXH) FY2028Q3 Earning Prediction

02/26 05:00:00

After Hours

MDxHealth SA (MDXH) is set to release its earnings performance on 02/26 05:00:00 in After Hours trading. Consensus forecasts predict a revenue of 23.16M and an earnings per share (EPS) of -0.20 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueBEAT

23.16M

24.69M

+6.61%

EPSBEAT

-0.20

-0.14

+30.00%

AI Summary

Attend Webcast

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

MDXH Transcript

MDxHealth SA (MDXH) Q3 2025 Earnings Call Transcript

Positive11-12

The earnings call presents a generally positive outlook, with a notable decrease in operating and net losses, and strong cash reserves. The Q&A highlights confidence in Exo's future contributions and sustained performance in GPS and Confirm products. Despite some avoidance in addressing ASP declines, the strategic focus on Exo and sales team expansion suggests growth potential. The absence of material negative factors and optimistic guidance point towards a positive stock price movement in the near term.

MDxHealth SA (MDXH) Q1 2025 Earnings Call Transcript

Unknown5-14

The earnings call presents a mixed picture: strong revenue growth and improved gross margins are offset by increased net losses and significant financial obligations. The absence of a share repurchase program and concerns over sustaining growth in a competitive market further temper positive sentiment. While management's optimistic guidance and effective market strategy are promising, the lack of specific guidance and financial challenges maintain a neutral outlook for the stock price in the near term.

MDxHealth SA (MDXH) Q4 2024 Earnings Call Transcript

Positive2-26

The earnings call summary shows strong revenue growth and improved financial metrics, with optimistic guidance and raised revenue projections for 2024 and beyond. Despite some risks and uncertainties, the Q&A reveals confidence in the company's strategic direction and market position. The absence of a shareholder return plan is a minor drawback, but overall, the positive financial performance and guidance outweigh potential concerns, suggesting a positive stock price movement.

MDxHealth SA (MDXH) Q3 2024 Earnings Call Transcript

Positive11-8

The earnings call summary indicates strong financial performance with a 32% revenue growth and raised guidance. Despite a decline in gross margins and increased operating loss, the company has a solid cash position post-equity financing. The Q&A highlighted management's confidence in meeting guidance and sustainable growth through urology adoption and test expansion. Analysts' questions reflected interest in growth levers and market dynamics, with no major concerns raised. The overall sentiment is positive, with potential stock price increase driven by raised guidance and sustainable growth outlook.

MDXH Report

Frequently Asked Questions

What is the MDxHealth SA FY2028Q3 Earnings Release Date and Time?

MDxHealth SA (MDXH) is scheduled to release its FY2028Q3 earnings report onFeb 26, 2025, After Hours(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for MDxHealth SA FY2028Q3 Revenue and EPS?

Analysts' consensus predicts 23.16M in revenue and an EPS of -0.20 for MDxHealth SA's FY2028Q3.

What Does Intellectia's AI Predict for MDxHealth SA FY2028Q3 Earnings?

Intellectia's exclusive AI algorithms forecast a forMDxHealth SA's FY2028Q3 earnings, with a prediction date of Feb 26, 2025. MDxHealth SA

How Can I Use This Earnings Prediction to Trade MDXH Stock?

Leverage Intellectia's AI forecast to position trades ahead of theFeb 26, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like MDxHealth SA FY2028Q3?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!